EPS BIO TECHNOLOGY CORP financial statements, including revenue, expenses, profit, and loss
The total revenue of 4183 for the last quarter is 150.63 M TWD, and it's 29.54% higher compared to the previous quarter. The net income of Q4 23 is 4.08 M TWD.